REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Strategic Review and Company Update

23 Nov 2023 07:00

RNS Number : 3938U
Hipgnosis Songs Fund Limited
23 November 2023
 

LEI: 213800XJIPNDVKXMOC11

 23 November 2023

 

Hipgnosis Songs Fund Limited

("Hipgnosis" or the "Company")

 

Strategic Review and Company Update

 

Further to the vote against the Company continuing its business as a closed-ended investment company at the Company's Annual General Meeting held on 26 October 2023, the Board announces an update on the strategic review (the "Strategic Review").

 

Update on the Strategic Review

As part of the Strategic Review, the Board intends to appoint independent advisers to conduct due diligence on the Company's assets.

 

Completion of this due diligence will provide a strong knowledge base from which the Board will commence a process of identifying and bringing forward alternative proposals for the future of the Company.

 

During this period, the Board has requested that Hipgnosis Song Management Limited, the Company's Investment Adviser ("Investment Adviser"), proposes alternative terms for their future investment advisory arrangements to the Company.

 

Audit Tender

The Company is currently undertaking an audit tender process for the 31 March 2024 audit. PwC have indicated they will not be participating in the tender. The Company will confirm the new auditor in due course.

 

Service of Claim

Further to the disclosure in the 2023 Annual Report, on page 100, Hipgnosis Music Limited (in liquidation since March 2018) ("Hipgnosis Music Limited") has served proceedings against Mr Mercuriadis, the Investment Adviser and the Company in the English High Court. In summary, Hipgnosis Music Limited alleges a diversion of business opportunity from Hipgnosis Music Limited (of which Mr Mercuriadis was previously a director) to the Company and the Investment Adviser and also alleges that the Company unlawfully assisted Mr Mercuriadis with, or received, this alleged diversion. Mr Mercuriadis, the Investment Adviser and the Company deny such claims and intend to vigorously defend them. The Company is not insured as to the costs of dealing with this claim.

 

For further information please contact:

 

Hipgnosis Songs Fund

Robert Naylor / Sylvia Coleman

Via Singer Capital Markets

 

Hipgnosis Song Management

Merck Mercuriadis

Ben Katovsky

Giles Croot (Media)

 

+44 (0) 20 7496 3000

 

 

 

+44 (0) 20 4542 1530

+44 (0) 20 4542 1511

 

Singer Capital Markets - Corporate Broker

James Moat / Alaina Wong / Angus Campbell (Corporate Finance)

Alan Geeves / James Waterlow / Sam Greatrex (Sales) 

+44 (0) 20 7496 3000

J.P. Morgan Cazenove - Corporate Broker

William Simmonds / Jérémie Birnbaum (Corporate Finance)

+44 (0) 20 3493 8000

RBC Capital Markets - Corporate Broker

Elliot Thomas / Max Avison (Corporate Finance)

 

Headland Consultancy - Financial PR

Susanna Voyle / Charlie Twigg

 

+44 (0) 20 7635 4000

 

 

+44 (0) 20 3805 4822

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDLLLLLXFLLFBV

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.